ReportLinker Find Industry reports, Company profiles and Market Statistics >> Get this Report Now by email! Discovery Stage Partnering Terms and Agreements in Pharma and Biotech Published on February 2014 Report Summary Provides comprehensive understanding and unprecedented access to the discovery stage partnering agreements entered into by the worlds leading biopharma companiesThe Discovery Stage Partnering Terms and Agreements in Pharma and Biotech report provides comprehensive understanding and unprecedented access to the discovery stage partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides a detailed understanding and analysis of how and why companies enter discovery stage partnering deals. The majority of deals are where the licensee obtains a right or an option right to license the licensors product or compound. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes. Understanding the flexibility of a prospective partner's negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered ' contract documents provide this insight where press releases do not. This report contains over 4,000 links to online copies of actual discovery stage deals and contract documents as submitted to the Securities Exchange Commission by companies and their partners. Contract documents provide the answers to numerous questions about a prospective partner's flexibility on a wide range of important issues, many of which will have a significant impact on each party's ability to derive value from the deal. The initial chapters of this report provide an orientation of discovery stage deal making and business activities. Chapter 1 provides an introduction to the report, whilst chapter 2 provides an overview of why companies partner discovery stage compounds/products. Chapter 3 provides an overview of discovery stage deals strategy and deal structure including numerous case studies. Chapter 4 provides an overview of the various payment strategies used in discovery stage deals. Chapter 5 provides a review of discovery stage deal making since 2009. Deals are listed by headline value, signed by big pharma, big biotech, and most active of all biopharma companies. Where the deal has an agreement contract published at the SEC a link provides online access to the contract. Chapter 6 provides a detailed analysis of discovery stage payment terms including average headline, upfront, milestone and royalty rates for discovery deals. Chapter 7 provides a review of the leading discovery stage deal by headline value. Chapter 8 provides a comprehensive listing of the top 50 big pharma and big biotech companies with a brief summary followed by a comprehensive listing of discovery stage deals, as well as contract documents available in the public domain. Where available, each deal title links via Weblink to an online version of the actual contract document, providing easy access to each contract document on demand. Discovery Stage Partnering Terms and Agreements in Pharma and Biotech (From Issuu) Page 1/22
22
Embed
Discovery Stage Partnering Terms and Agreements in Pharma and Biotech
Provides comprehensive understanding and unprecedented access to the discovery stage partnering agreements entered into by the worlds leading biopharma companiesThe Discovery Stage Partnering Terms and Agreements in Pharma and Biotech report provides comprehensive understanding and unprecedented access to the discovery stage partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides a detailed understanding and analysis of how and why companies enter discovery stage partnering deals. The majority of deals are where the licensee obtains a right or an option right to license the licensors product or compound. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes. Understanding the flexibility of a prospective partner's negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many sm...
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
ReportLinker Find Industry reports, Company profilesand Market Statistics
>> Get this Report Now by email!
Discovery Stage Partnering Terms and Agreements in Pharma and
Biotech
Published on February 2014
Report Summary
Provides comprehensive understanding and unprecedented access to the discovery stage partnering agreements entered into by the
worlds leading biopharma companiesThe Discovery Stage Partnering Terms and Agreements in Pharma and Biotech report provides
comprehensive understanding and unprecedented access to the discovery stage partnering deals and agreements entered into by the
worlds leading healthcare companies.
The report provides a detailed understanding and analysis of how and why companies enter discovery stage partnering deals. The
majority of deals are where the licensee obtains a right or an option right to license the licensors product or compound. These deals
tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes.
Understanding the flexibility of a prospective partner's negotiated deals terms provides critical insight into the negotiation process in
terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the
payments clauses, the devil is in the detail in terms of how payments are triggered ' contract documents provide this insight where
press releases do not.
This report contains over 4,000 links to online copies of actual discovery stage deals and contract documents as submitted to the
Securities Exchange Commission by companies and their partners. Contract documents provide the answers to numerous questions
about a prospective partner's flexibility on a wide range of important issues, many of which will have a significant impact on each
party's ability to derive value from the deal.
The initial chapters of this report provide an orientation of discovery stage deal making and business activities. Chapter 1 provides an
introduction to the report, whilst chapter 2 provides an overview of why companies partner discovery stage compounds/products.
Chapter 3 provides an overview of discovery stage deals strategy and deal structure including numerous case studies. Chapter 4
provides an overview of the various payment strategies used in discovery stage deals.
Chapter 5 provides a review of discovery stage deal making since 2009. Deals are listed by headline value, signed by big pharma, big
biotech, and most active of all biopharma companies. Where the deal has an agreement contract published at the SEC a link provides
online access to the contract.
Chapter 6 provides a detailed analysis of discovery stage payment terms including average headline, upfront, milestone and royalty
rates for discovery deals.
Chapter 7 provides a review of the leading discovery stage deal by headline value.
Chapter 8 provides a comprehensive listing of the top 50 big pharma and big biotech companies with a brief summary followed by a
comprehensive listing of discovery stage deals, as well as contract documents available in the public domain. Where available, each
deal title links via Weblink to an online version of the actual contract document, providing easy access to each contract document on
demand.
Discovery Stage Partnering Terms and Agreements in Pharma and Biotech (From Issuu) Page 1/22
ReportLinker Find Industry reports, Company profilesand Market Statistics
>> Get this Report Now by email!Fax Order Form To place an order via fax simply print this form, fill in the information below and fax the completed form to:
Europe, Middle East and Africa : + 33 4 37 37 15 56 Asia, Oceania and America : + 1 (805) 617 17 93
If you have any questions please visit http://www.reportlinker.com/notify/contact Order Information Please verify that the product information is correct and select the format(s) you require.
Product Formats Please select the product formats and the quantity you require.
Contact Information Please enter all the information below in BLOCK CAPITALS Title: Mr Mrs Dr Miss Ms Prof First Name: _____________________________ Last Name: __________________________________ Email Address: __________________________________________________________________________ Job Title: __________________________________________________________________________ Organization: __________________________________________________________________________ Address: __________________________________________________________________________ City: __________________________________________________________________________ Postal / Zip Code: __________________________________________________________________________ Country: __________________________________________________________________________ Phone Number: __________________________________________________________________________ Fax Number: __________________________________________________________________________
Discovery Stage Partnering Terms and Agreements in Pharma and Biotech
1 User License--USD 3 295.00 Quantity: _____
CD-ROM--USD 3 795.00 Quantity: _____
2-5 User License--USD 4 995.00 Quantity: _____
Site License--USD 9 895.00 Quantity: _____
Corporate License--USD 16 495.00 Quantity: _____
Discovery Stage Partnering Terms and Agreements in Pharma and Biotech (From Issuu) Page 21/22